参考文献/References:
[1] 林慧,梁琦强,蔡旗旗,等.脓毒症相关性肝损伤的高危因素及临床特点分析[J].中华危重病急救医学,2021,33(2):186-191.
[2] 丁烨,戴璐,向雅婷,等.程序性死亡蛋白1(PD-1)及其配体PD-L1在脓毒症免疫细胞功能障碍中的作用及其应用[J].细胞与分子免疫学杂志,2020,36(9):843-848.
[3] PAUDEL Y N,ANGELOPOULOU E,PIPERI C,et al.Enlightening the role of high mobility group box 1(HMGB1)in inflammation:Updates on receptor signalling[J].Eur J Pharmacol,2019,858(1):172487.
[4] SINGER M,DEUTSCHMAN C S,SEYMOUR C W,et al. The third international consensus definitions for sepsis and septic shock(sepsis-3)[J].JAMA,2016,315(8):801-810.
[5] WOZNICA-NIESOBSKA E,LESNIK P,JANC J,et al. The-role of plasminogen activator inhibitor 1 in predicting sepsis-associated liver dysfunction:An observational study[J].Int J Environ Res Public Health,2023,20(6):4846-4857.
[6] 黄飞,祁玮,何健,等.感染部位与发生脓毒症肝损伤的相关性研究[J].临床急诊杂志,2021,22(10):653-656.
[7] 高飞,惠姣洁,杨岚,等.中性粒细胞功能在脓毒症肝损伤中的变化及其对预后的影响:一项前瞻性观察性研究[J].中华危重病急救医学,2019,31(11):1324-1329.
[8] 王宗培,谢智慧,赵玉洁,等.共刺激分子程序性细胞死亡受体-1/程序性细胞死亡受体配体-1调控树突状细胞对脓毒症患者免疫功能的影响[J].中华危重病急救医学,2021,33(9):1032-1039.
[9] 张毳毳,白和平,吕晓燕.血高迁移率族蛋白-1对创伤所致严重脓毒症患者心功能及预后的预测价值[J].临床和实验医学杂志,2021,20(21):2293-2296.
[10] YANG R,ZOU X,TENHUNEN J,et al.HMGB1 and extracellular histones significantly contribute to systemic inflammation and multiple organ failure in acute liver failure[J].Mediators Inflamm,2017,3(1):592-608.
[11] ANDERSSON U,YANG H,HARRIS H. Extracellular HMGB1 as a therapeutic target in inflammatory diseases[J].Expert Opin Ther Targets,2018,22(3):263-277.